Suchergebnisse - "Bonjoch, A"

PubPharm (38)

1

Neurocognitive safety after 96 weeks on dual therapy with atazanavir/ritonavir plus lamivudine : results of the neurocognitive substudy of the SALT randomized clinical trial

enthalten in: The Journal of antimicrobial chemotherapy | 2018

von Pérez-Valero, I. | Pasquau, J. | Rubio, R. | +112

2

Significant improvement in triglyceride levels after switching from ritonavir to cobicistat in suppressed HIV-1-infected subjects with dyslipidaemia

enthalten in: HIV medicine | 2017

von Echeverría, P. | Bonjoch, A. | Puig, J. | +3

3

Variable endothelial cell function restoration after initiation of two antiretroviral regimens in HIV-infected individuals

enthalten in: The Journal of antimicrobial chemotherapy | 2017

von Echeverría, P. | Gómez-Mora, E. | Roura, S. | +7

4

Simplification to dual therapy (atazanavir/ritonavir + lamivudine) versus standard triple therapy [atazanavir/ritonavir + two nucleos(t)ides] in virologically stable patients on antiretroviral therapy : 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study)

enthalten in: The Journal of antimicrobial chemotherapy | 2017

von Perez-Molina, J. | Rubio, R. | Rivero, A. | +113

5

Significant improvement in triglyceride levels after switching from ritonavir to cobicistat in suppressed HIV‐1‐infected subjects with dyslipidaemia

enthalten in: HIV medicine | 2017

von Echeverría, P. | Bonjoch, A. | Puig, J. | +3

6

Significant improvement in triglyceride levels after switching from ritonavir to cobicistat in suppressed HIV‐1‐infected subjects with dyslipidaemia

enthalten in: HIV Medicine | 2017

von Echeverría, P. | Bonjoch, A. | Puig, J. | +3

7

Comparison of two different strategies of treatment with zoledronate in HIV-infected patients with low bone mineral density : single dose versus two doses in 2 years

enthalten in: HIV medicine | 2015

von Negredo, E. | Bonjoch, A. | Pérez-Álvarez, N. | +8

8

Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT) : 48 week results from a randomised, open-label, non-inferiority trial

enthalten in: The Lancet. Infectious diseases | 2015

von Perez-Molina, J. | Rubio, R. | Rivero, A. | +114

CommentIn: Lancet Infect Dis. 2015 Jul;15(7):748-9. - PMID 26062879

9

Comparison of two different strategies of treatment with zoledronate in HIV‐infected patients with low bone mineral density: single dose versus two doses in 2 years

enthalten in: HIV medicine | 2015

von Negredo, E. | Bonjoch, A. | Pérez‐Álvarez, N. | +8

10

Oral human papillomavirus type-specific infection in HIV-infected men : a prospective cohort study among men who have sex with men and heterosexual men

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2014

von Darwich, L. | Cañadas, M. | Videla, S. | +32